G&E Herbal Biotechnology Co., LTD   Report issue

For profit Phase 2 Phase 3
Founded: Shanhua Township Taiwan (2002)
Status: No NME R&D (2002)

Organization Overview

First Clinical Trial
2007
NCT02085395
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

Solanum incanum extract (4 trials)

Drugs in Phase 2 Trials (1)

solamargine (4 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bowen's Disease (Phase 2)

Carcinoma in Situ (Phase 1)

Condylomata Acuminata (Phase 2)

Keratosis (Phase 3)

Keratosis, Actinic (Phase 3)

Neoplasms (Phase 1)

Warts (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 8
  • # of Trial APIs: 2